For the fiscal year ending December 2025, revenue was 496.8 billion yen, flat year-over-year, core operating income was 127.9 billion yen, down 4% year-over-year, and net income attributable to owners of parent was 67.0 billion yen, up 12% year-over-year.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4151","jir_company_name":"Kyowa Kirin Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-02-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4151-20260209-02.pdf","jir_short_summary":"For the fiscal year ending December 2025, revenue was 496.8 billion yen, flat year-over-year, core operating income was 127.9 billion yen, down 4% year-over-year, and net income attributable to owners of parent was 67.0 billion yen, up 12% year-over-year.","jir_summary":"### Business Overview\nKyowa Kirin Co., Ltd.'s consolidated performance for the fiscal year ending December 2025 showed revenue of 496.8 billion yen, nearly flat year-over-year. Core operating income was 127.9 billion yen, down 4% year-over-year; however, net income attributable to owners of parent increased 12% to 67.0 billion yen. Research and development expenses were 101.2 billion yen, down 2% YoY, with an R&D expense ratio of 20.4%. The overseas sales ratio rose to 74%, reflecting progress in global expansion. Sales of key products were strong, with Crysvita achieving 216.4 billion yen (9% increase YoY) and Poteligeo recording 45.7 billion yen (20% increase YoY).\n\n### Outlook and Development Pipeline\nFor 2026, revenue is forecast at 520.0 billion yen (5% increase YoY) and core operating income at 129.0 billion yen (1% increase YoY). Capital expenditures are planned at 33.9 billion yen, and intangible asset investments at 18.3 billion yen. The development pipeline includes multiple global development products such as ziftomenib (KOMZIFTI) and KHK4083\/AMG 451 (locatinlimab). In September 2025, following the termination of the collaboration agreement with Amgen Inc., rights to KHK4083 were reacquired. These new drug developments are expected to drive future growth.","jir_financial_highlights":"Revenue: 496.8 billion yen (0% increase YoY)\nCore Operating Income: 127.9 billion yen (4% decrease YoY)\nNet Income Attributable to Owners of Parent (Quarterly): 67.0 billion yen (12% increase YoY)\nResearch and Development Expenses: 101.2 billion yen (2% decrease YoY)\nAnnual Dividend (yen\/share): 60.00 yen (4.00 yen increase YoY)\nOverseas Sales Ratio: 74% (Increase YoY)","jir_category":"","jir_hashtags":"#KyowaKirinCoLtd, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Revenue: 496.8 billion yen (Fiscal Year Ending December 2025 Results, 0% increase YoY)\nCore Operating Income: 127.9 billion yen (Fiscal Year Ending December 2025 Results, 4% decrease YoY)\nNet Income Attributable to Owners of Parent (Quarterly): 67.0 billion yen (Fiscal Year Ending December 2025 Results, 12% increase YoY)","jir_meta_title":"Kyowa Kirin Fiscal Year Dec 2025 Financial Summary Supplemental Material Revenue 496.8 Billion Yen Net Income 67.0 Billion Yen","jir_meta_description":"Supplemental materials for Kyowa Kirin Co., Ltd.\u2019s Fiscal Year Dec 2025 Financial Summary. Reporting revenue of 496.8 billion yen, core operating income of 127.9 billion yen, and net income of 67.0 billion yen. Highlights include strong performance of key products and an overseas sales ratio of 74%.","jir_og_title":"Kyowa Kirin Fiscal Year Dec 2025 Financial Summary Supplemental Material Released","jir_og_description":"Kyowa Kirin's supplemental materials for the fiscal year ending December 2025 financial summary. Revenue of 496.8 billion yen and net income of 67.0 billion yen increased year-over-year. Detailed information on key product status is also included.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend (2024, 2025, 2026 Forecast)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Jan-Mar\\\",\\\"Jan-Jun\\\",\\\"Jan-Sep\\\",\\\"Jan-Dec\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"2024 Actual\\\",\\\"data\\\":[1056,2330,3628,4956],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false},{\\\"label\\\":\\\"2025 Actual\\\",\\\"data\\\":[1047,2307,3495,4968],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false},{\\\"label\\\":\\\"2026 Forecast\\\",\\\"data\\\":[null,null,null,5200],\\\"borderColor\\\":\\\"#3cba9f\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Core Operating Income Trend (2024, 2025, 2026 Forecast)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Jan-Mar\\\",\\\"Jan-Jun\\\",\\\"Jan-Sep\\\",\\\"Jan-Dec\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"2024 Actual\\\",\\\"data\\\":[179,445,768,994],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false},{\\\"label\\\":\\\"2025 Actual\\\",\\\"data\\\":[112,368,661,1098],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false},{\\\"label\\\":\\\"2026 Forecast\\\",\\\"data\\\":[null,null,null,1290],\\\"borderColor\\\":\\\"#3cba9f\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Revenue by Regional Headquarters (Fiscal Year Ending December 2025 Results)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Japan\\\",\\\"North America\\\",\\\"EMEA\\\",\\\"Others\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue (billion yen)\\\",\\\"data\\\":[128.8,192.5,83.7,98.1],\\\"backgroundColor\\\":[\\\"#3e95cd\\\",\\\"#8e5ea2\\\",\\\"#3cba9f\\\",\\\"#e8c3b9\\\"]}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"product_revenue_top5\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Top 5 Product Revenues (Fiscal Year Ending December 2025 Results)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Crysvita\uff0f\u30af\u30ea\u30fc\u30b9\u30d3\u30fc\u30bf\\\",\\\"Poteligeo\uff0f\u30dd\u30c6\u30ea\u30b8\u30aa\\\",\\\"Libmeldy\uff0fLenmeldy\\\",\\\"Nourianz\\\",\\\"Fozebel\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Revenue (billion yen)\\\",\\\"data\\\":[216.4,45.7,6.4,9.5,8.2],\\\"backgroundColor\\\":\\\"#3e95cd\\\"}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"display\\\":false}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"cash_flow_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Cash Flow Trend (2024 & 2025)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Jan-Mar\\\",\\\"Jan-Jun\\\",\\\"Jan-Sep\\\",\\\"Jan-Dec\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Cash Flow from Operating Activities (2024)\\\",\\\"data\\\":[3331,3111,2963,2447],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false},{\\\"label\\\":\\\"Cash Flow from Operating Activities (2025)\\\",\\\"data\\\":[2144,2346,2402,2188],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true,\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}},\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":7472,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-26035","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n